Traws Pharma, Inc. — Director's Dealing 2015

Jul 8, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2015-07-01

Reporting Person: MARINO JAMES J (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to purchase)	$2.37	2025-07-01	Common Stock (30000)		Direct

Footnotes

F1: These options vest 33% on July 1, 2016, 33% on July 1, 2017 and 34% on July 1, 2018.